DIGITALDX
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video
Picture
Michael Solotke, MD, MBA
  • MD/MBA candidate at Yale School of Medicine and Yale School of Management
  • BS in Molecular Biophysics & Biochemistry at Yale
  • Health services researcher at Yale Center for Outcomes Research & Evaluation
  • Authored 11 research publications
  • Former healthcare consultant at IQVIA (previously IMS Health)​
  • Are you developing an impact measurement strategy?
Michael is an MD/MBA candidate at Yale. As a future OBGYN and a former patient, he cares deeply about healthcare innovation, health equity, medical policy, and the value of early diagnosis. His research has focused on FDA drug safety warnings and their impact on reimbursement, access to medicines and healthcare services, and medical education. Prior to attending medical school, Michael spent 3 years as a healthcare consultant at IQVIA (formerly IMS Health), focusing on strategy, commercialization, pricing, and data analytics. Consulting project highlights include optimizing R&D processes within a large research organization, analyzing the use of value frameworks by various stakeholders, leading long-term strategic planning at a major biotechnology firm, and facilitating post-merger integration at a top pharmaceutical company.

Michael holds a BS in Molecular Biophysics & Biochemistry from Yale. In addition to his healthcare interests, he maintains a career as a professional carillonneur, reads copiously, runs often, and loves experimental cooking.
Disclaimer
Terms & Conditions
Privacy Policy
Investment Inquiries
Contact
Picture
Picture
Picture
 Copyright © 2022 All Rights Reserved
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video